NS

Nadipi Sriranjani

Active Director Director DIN 09300374
DIN 09300374 First appointment Aug 2021 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2021
Shareholding value •••• Premium profile

About Nadipi Sriranjani

Data last updated:

Nadipi Sriranjani is a Director at Highind Pharma Care India Private Limited (since 2021). The company operates in Pharma. Highind Pharma Care India Private Limited reported revenue of ₹57.4 Lakh (FY 2024).

DIN 09300374
Primary Designation Director
Industry Pharma
First Appointment 31 Aug 2021
Oldest Company Age 5 yrs
Largest company Highind Pharma Care India Private Limited · ₹57.4 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director31 Aug 20212021₹57.4 Lakh (FY 2024)Active

Board colleagues of Nadipi Sriranjani

Directorship timeline

Open interactive timeline →
Highind Pharma Care India Private Limited
Premium access

Shareholding and investment profile for Nadipi Sriranjani

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nadipi Sriranjani

Nadipi Sriranjani currently holds 1 directorship: Highind Pharma Care India Private Limited (Director, since 31 Aug 2021, revenue ₹57.4 Lakh (FY 2024)).

Nadipi Sriranjani was first appointed on 31 Aug 2021 as Director at Highind Pharma Care India Private Limited.

The current boards of Nadipi Sriranjani's companies include Gajula Venkata Sasi Kumar (Highind Pharma Care India Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available